Clinical features and long-term outcome of a group of Japanese children with inflammatory central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein antibodies

Brain and Development

Volumn 37, Issue 9, 2015, Pages 849-852

  Hino Fukuyo, Naomi ^a   Haginoya, Kazuhiro ^a   Nakashima, Ichiro ^a   Sato, Douglas Kazutoshi ^a   Takahashi, Toshiyuki ^a   Misu, Tatsuro ^a   Fujihara, Kazuo ^a   Hirose, Mieko ^a   Kakisaka, Yosuke ^a   Uematsu, Mitsugu ^a   Kobayashi, Tomoko ^a   Kure, Shigeo ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute disseminated encephalomyelitis; Multiple sclerosis; Myelin oligodendrocyte glycoprotein; Neuromyelitis optica; Optic neuritis

Indexed keywords

AQUAPORIN 4; BETA INTERFERON; METHYLPREDNISOLONE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY; AQP4 PROTEIN, HUMAN;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADOLESCENT; ANTIBODY TITER; ARTICLE; CELL ASSAY; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL OBSERVATION; CONTROLLED STUDY; DEMYELINATING DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; FEMALE; HUMAN; INFLAMMATION; JAPANESE (PEOPLE); LONG TERM CARE; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; OPTIC NEURITIS; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRESCHOOL CHILD; PROGNOSIS; SCHOOL CHILD; SEROLOGY; SERUM; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; IMMUNOLOGY; INFANT; JAPAN; NEUROMYELITIS OPTICA;

ADOLESCENT; ANTIBODIES; AQUAPORIN 4; CHILD; CHILD, PRESCHOOL; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEMALE; HUMANS; INFANT; JAPAN; MALE; MULTIPLE SCLEROSIS; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NEUROMYELITIS OPTICA;

EID: 84938114162     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2015.02.006     Document Type: Article

References (6)

1. Rostasy K., Reindl M. Role of autoantibodies in acquired inflammatory demyelinating diseases of the central nervous system in children. Neuropediatrics 2013, 44:297-301.
2. Reindl M., Di Pauli F., Rostasy K., Berger T. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 2013, 9:455-461.
3. Krupp L.B., Tardieu M., Amato M.P., Banwell B., Chitnis T., Dale R.C., et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 2013, 19:1261-1267.
4. Sato D.K., Nakashima I., Takahashi T., Misu T., Waters P., Kuroda H., et al. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology 2013, 80:2210-2216.
5. Sato D.K., Callegaro D., Lana-Peixoto M.A., Waters P.J., de Haidar Jorge F.M., Takahashi T., et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 2014, 82:474-481.
6. Kitley J., Waters P., Woodhall M., Leite M.I., Murchison A., George J., et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol 2014, 71:276-283.